Business Segment and Geographic Data Information (Information Concerning Consolidated Operations by Business Segment) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Net Sales	$ 5,176	$ 5,382	$ 5,259	$ 5,029	$ 5,075	$ 4,979	$ 4,857	$ 4,835	$ 20,846		$ 19,746		$ 19,115
Operating Profit	611	662	625	544	699	698	711	665	2,442	[1],[2]	2,773	[1],[2]	2,825	[1],[2]
Depreciation and Amortization									1,091		813		783
Assets	19,373				19,864				19,373		19,864		19,209
Capital Spending									968		964		848
Restructuring Charges									415
Income Tax Reconciliation, Nondeductible Expense									32
Charge for adoption of highly inflationary accounting									98		98
Personal Care [Member]
Net Sales									9,128		8,670		8,365
Operating Profit									1,526	[1]	1,764	[1]	1,739	[1]
Depreciation and Amortization									296		277		255
Assets	6,582				6,316				6,582		6,316		5,895
Capital Spending									543		436		440
Charge for adoption of highly inflationary accounting											11
Consumer Tissue [Member]
Net Sales									6,770		6,497		6,409
Operating Profit									775	[1]	660	[1]	736	[1]
Depreciation and Amortization									541		329		314
Assets	5,685				6,106				5,685		6,106		5,871
Capital Spending									255		331		271
Restructuring Charges									357
Charge for adoption of highly inflationary accounting											6
K-C Professional and Other [Member]
Net Sales									3,294		3,110		3,007
Operating Profit									487	[1]	468	[1]	464	[1]
Depreciation and Amortization									187		142		148
Assets	2,783				2,962				2,783		2,962		2,969
Capital Spending									114		156		97
Restructuring Charges									56
Charge for adoption of highly inflationary accounting											2
Health Care [Member]
Net Sales									1,606		1,460		1,371
Operating Profit									219	[1]	174	[1]	244	[1]
Depreciation and Amortization									55		56		50
Assets	2,529				2,410				2,529		2,410		2,558
Capital Spending									53		40		38
Corporate and Other [Member]
Net Sales									48		9		(37)
Operating Profit									(565)	[1],[3]	(293)	[1],[4]	(358)	[1]
Depreciation and Amortization									12		9		16
Assets	1,794				2,070				1,794		2,070		1,916
Capital Spending									3		1		2
Other (Income) And Expense, Net [Member]
Restructuring Charges									2
Highly Inflationary Accounting For Venezuelan Operations [Member]
Other (income) and expense, net											79
Other (income) and expense, net											$ 79

[1] Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segment

[2] Geographic operating profit excludes Other (income) and expense, net and income and expenses not associated with geographic areas.

[3] Pulp and tissue restructuring charges of $415 million and a non-deductible business tax charge of $32 million related to a law change in Colombia are included in Corporate & Other in 2011. See additional information related to the pulp and tissue restructuring in Note 2.

[4] Included in Corporate & Other in 2010 is a $98 million charge related to the adoption of highly inflationary accounting in Venezuela effective January 1, 2010. See additional information in Note 3.